Matches in Wikidata for { <http://www.wikidata.org/entity/Q88688841> ?p ?o ?g. }
- Q88688841 description "article scientifique publié en 2018" @default.
- Q88688841 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q88688841 description "scientific article published on 01 June 2018" @default.
- Q88688841 description "wetenschappelijk artikel" @default.
- Q88688841 description "наукова стаття, опублікована в червні 2018" @default.
- Q88688841 name "Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial" @default.
- Q88688841 name "Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial" @default.
- Q88688841 type Item @default.
- Q88688841 label "Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial" @default.
- Q88688841 label "Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial" @default.
- Q88688841 prefLabel "Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial" @default.
- Q88688841 prefLabel "Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial" @default.
- Q88688841 P1433 Q88688841-313671AC-6E33-4C95-9DEC-F6DCD168A6A5 @default.
- Q88688841 P1476 Q88688841-6C8159B1-18DD-43E7-8699-A5CDEAE7D9FE @default.
- Q88688841 P2093 Q88688841-2CCFCFDC-2DB7-4D4A-8B96-07312D71124A @default.
- Q88688841 P2093 Q88688841-31FE9409-9AA9-4CD3-8EDB-5CA6E2F70D3E @default.
- Q88688841 P2093 Q88688841-415C01B9-63B5-4EFE-A8B7-F2235813FA24 @default.
- Q88688841 P2093 Q88688841-7DEED8AA-31B8-4156-B54C-EC985D3C4F21 @default.
- Q88688841 P2093 Q88688841-95BCC579-70B5-4FE4-A2E9-A9D94FEF853D @default.
- Q88688841 P2093 Q88688841-9C94232C-1E39-42B0-9AE1-81ACF86B724F @default.
- Q88688841 P2093 Q88688841-A7FABA61-0E59-404E-9A47-1D6A7C143C08 @default.
- Q88688841 P2093 Q88688841-ACBC9A1C-FF9B-4619-BF46-8475FF41BD26 @default.
- Q88688841 P2093 Q88688841-CA373CFE-A296-4511-9054-AE0FA9C39124 @default.
- Q88688841 P2093 Q88688841-EFD86771-CCDF-4B16-80E6-0B83EA23665B @default.
- Q88688841 P2860 Q88688841-0E3BC124-E937-4A37-8042-D61A9B8FFBC6 @default.
- Q88688841 P2860 Q88688841-1126AB69-A99F-426B-8F72-B14C05F49F89 @default.
- Q88688841 P2860 Q88688841-12A1C492-1454-4747-8874-2B8A2A8356E2 @default.
- Q88688841 P2860 Q88688841-171D6B1F-A285-4BE4-A68E-2AB9AB0D08BE @default.
- Q88688841 P2860 Q88688841-183F4B6D-6BA8-4901-848F-7542CB91F49E @default.
- Q88688841 P2860 Q88688841-1D123E4B-D52C-4FE7-9BF6-0D2ED92CF658 @default.
- Q88688841 P2860 Q88688841-25343ED6-6FD0-4408-A03D-03669382C1B4 @default.
- Q88688841 P2860 Q88688841-2B30C051-291B-438B-9394-A365C397174B @default.
- Q88688841 P2860 Q88688841-31AECD87-E713-4142-8C96-D8AA4EA95ABE @default.
- Q88688841 P2860 Q88688841-35723563-BC52-4793-A80A-1235A0625B15 @default.
- Q88688841 P2860 Q88688841-387A105B-4FEF-43F2-AE9B-8EBD86A088E8 @default.
- Q88688841 P2860 Q88688841-44FCFC67-94FF-4A2F-BDBD-41DFFBE4580E @default.
- Q88688841 P2860 Q88688841-4EF49FF8-55FB-4588-93A3-7453A98A71E5 @default.
- Q88688841 P2860 Q88688841-510CCF1F-B41B-4CB8-89CC-2EE6F6F231C6 @default.
- Q88688841 P2860 Q88688841-51E9436F-83A4-4554-A3C5-B078A6397C27 @default.
- Q88688841 P2860 Q88688841-54AA955B-512D-40DF-B422-5A429B7BBBDB @default.
- Q88688841 P2860 Q88688841-6B1ECBF3-D0CA-442B-8E6D-875CD9ED8623 @default.
- Q88688841 P2860 Q88688841-835282A5-66C9-458E-83F3-813E7E01D05D @default.
- Q88688841 P2860 Q88688841-91B99EEF-63AE-45FF-BEC2-A93A7AD54FC8 @default.
- Q88688841 P2860 Q88688841-9B0A0AB5-D78C-419C-9E9B-C06F8A164D55 @default.
- Q88688841 P2860 Q88688841-A1BF047D-A94D-4520-B7BE-7809A0B9DD58 @default.
- Q88688841 P2860 Q88688841-B7FB5EB0-D579-4F47-8D03-8CE5CE72B2D1 @default.
- Q88688841 P2860 Q88688841-BAAB4B9F-80B8-4F82-A494-1FB1303EB62F @default.
- Q88688841 P2860 Q88688841-BE62AC98-EE97-4C37-9A88-F32DC9AAD838 @default.
- Q88688841 P2860 Q88688841-CA32708F-B9DD-4272-BD8D-39BCD1A0F937 @default.
- Q88688841 P2860 Q88688841-CB90F31B-F31E-43C6-8B11-7F346EC24D4F @default.
- Q88688841 P2860 Q88688841-CF34FBFB-DDE1-4B7E-8885-93FD35CD20C8 @default.
- Q88688841 P2860 Q88688841-D66600E2-7D33-4D7B-8318-329F98F05E33 @default.
- Q88688841 P2860 Q88688841-E30F3A6F-A98B-41FE-AA41-770D60DB2110 @default.
- Q88688841 P2860 Q88688841-E3CEA4CD-74AA-469B-B701-6D4049CB8759 @default.
- Q88688841 P2860 Q88688841-EF744B2F-430A-48FA-A671-23E57A4E1C44 @default.
- Q88688841 P2860 Q88688841-FFC2CDC9-47BA-4E7B-B798-CC3474741D01 @default.
- Q88688841 P304 Q88688841-8F87B414-2C4F-44AD-A082-0C69A889ED1B @default.
- Q88688841 P31 Q88688841-A41BE39A-2171-4F21-80C9-7C803C23F219 @default.
- Q88688841 P356 Q88688841-3F780F39-A085-4D01-AC09-BA2ECF05AD54 @default.
- Q88688841 P433 Q88688841-9C1D8D76-94F4-45AC-9BAF-D1B74DBCD4EB @default.
- Q88688841 P478 Q88688841-50F2FD21-C4E3-4F2F-A15B-648AA58C8176 @default.
- Q88688841 P577 Q88688841-FD286CE2-E938-4144-A55F-F01ED11AC544 @default.
- Q88688841 P698 Q88688841-F5DE8F9C-9BBA-4BE4-9245-9BEDFFDA0054 @default.
- Q88688841 P921 Q88688841-1415419E-17D7-4573-92E8-D7975784281E @default.
- Q88688841 P921 Q88688841-39C5B506-EDDE-4A1F-8464-69EFC4ACA715 @default.
- Q88688841 P921 Q88688841-84C9C9C4-71D8-47BF-AE1B-A16EA24D3BEF @default.
- Q88688841 P921 Q88688841-C48EAE1C-7895-4EF6-AB59-3590AF51D57A @default.
- Q88688841 P921 Q88688841-F4AB4252-7693-4ED9-9874-DA7803F7684E @default.
- Q88688841 P932 Q88688841-408382B7-938F-4259-AAEE-E72FC43E31B1 @default.
- Q88688841 P356 DOM.13352 @default.
- Q88688841 P698 29766636 @default.
- Q88688841 P1433 Q5270109 @default.
- Q88688841 P1476 "Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial" @default.
- Q88688841 P2093 "Christopher Lee" @default.
- Q88688841 P2093 "Fernando Solimando" @default.
- Q88688841 P2093 "Gang Cheng" @default.
- Q88688841 P2093 "Jisoo Lee" @default.
- Q88688841 P2093 "Jyothis George" @default.
- Q88688841 P2093 "Keiko Suzaki" @default.
- Q88688841 P2093 "Kosuke Shiki" @default.
- Q88688841 P2093 "Masakazu Haneda" @default.
- Q88688841 P2093 "Ryuzo Kawamori" @default.
- Q88688841 P2093 "Yuki Miyamoto" @default.
- Q88688841 P2860 Q28080114 @default.
- Q88688841 P2860 Q28254549 @default.
- Q88688841 P2860 Q30588344 @default.
- Q88688841 P2860 Q33835558 @default.
- Q88688841 P2860 Q33890770 @default.
- Q88688841 P2860 Q34673134 @default.
- Q88688841 P2860 Q34898643 @default.
- Q88688841 P2860 Q35330816 @default.
- Q88688841 P2860 Q35962994 @default.
- Q88688841 P2860 Q36428096 @default.
- Q88688841 P2860 Q37468440 @default.
- Q88688841 P2860 Q37496434 @default.
- Q88688841 P2860 Q37524302 @default.
- Q88688841 P2860 Q37913523 @default.
- Q88688841 P2860 Q38076330 @default.
- Q88688841 P2860 Q38546981 @default.
- Q88688841 P2860 Q38863649 @default.